April 29

2015

Q&A: Mayer Brown's Brian Nolan on strategy behind drug patent challenges

Reuters (subscription required)

Home
News
Q&A: Mayer Brown's Brian Nolan on strategy behind drug patent challenges

Related People

Brian W. Nolan

In this Q&A interview, Intellectual Property partner Brian Nolan (New York) discusses strategy behind drug patent challenges.

Related Capabilities

Practices –

Industries –

Life Sciences

News

October 18

2019

Mayer Brown named among Top 10 firms for leadership and diversity & inclusion in IP
October 15

2019

Rising Star: Allison Stillman

New York Law Journal
October 10

2019

Gabriela Kennedy listed in WTR Global Leaders 2019
October 09

2019

Mayer Brown associate Amanda Bonner recognized in PTAB Bar Association’s list of “Top 50 Women in PTAB Trials”
October 03

2019

Mayer Brown recognized as a “Litigation Powerhouse and Standout” in BTI Litigation Outlook 2020 report